# CDNF

## Overview
Cerebral dopamine neurotrophic factor (CDNF) is a gene that encodes a protein of the same name, which plays a crucial role in neuroprotection and cellular stress responses. The CDNF protein is categorized as a neurotrophic factor and is primarily located in the endoplasmic reticulum (ER) lumen, where it is involved in maintaining ER homeostasis and promoting cell survival under stress conditions. Structurally, CDNF is characterized by an N-terminal saposin-like domain and a C-terminal SAP-like domain, which are essential for its interactions with ER chaperones and its function in the unfolded protein response (UPR) (Lindholm2021Cerebral; Lindahl2017Unconventional). The protein's ability to modulate UPR pathways, particularly through interactions with GRP78 and GRP170, underscores its significance in managing ER stress and promoting neuronal survival (Graewert2024Structural; Eesmaa2022CDNF). CDNF's neuroprotective properties are of particular interest in the context of neurodegenerative diseases, such as Parkinson's disease, where it holds potential as a therapeutic agent (Huttunen2019CDNF).

## Structure
The cerebral dopamine neurotrophic factor (CDNF) protein is characterized by a unique molecular structure comprising two distinct domains: an N-terminal saposin-like domain and a C-terminal SAP-like domain. The N-terminal domain is involved in lipid interactions, typical of saposin-like proteins, and is stabilized by three intramolecular disulfide bonds (Lindholm2021Cerebral; Lindahl2017Unconventional). The C-terminal domain contains a conserved CXXC motif and an ER retention signal, suggesting a role in endoplasmic reticulum stress response (Stepanova2020Cerebral; Tang2017Cerebral).

The primary structure of CDNF includes a signal peptide that is cleaved to produce a mature protein of 161 amino acids (Lindahl2017Unconventional). The secondary structure features eight alpha-helices, with the N-terminal domain forming a closed globular conformation (Parkash2009The; Tang2017Cerebral). The tertiary structure is characterized by a flexible linker between the two domains, allowing for dynamic interactions (Lindahl2017Unconventional).

CDNF can form a domain-swapped dimer in an open conformation, although it behaves as a monomer under physiological conditions (Parkash2009The). Glycosylation is not required for its secretion or neuroprotective activity (Lindahl2017Unconventional). The protein's structure and function are crucial for its role in neuroprotection and the unfolded protein response.

## Function
Cerebral dopamine neurotrophic factor (CDNF) is a protein primarily located in the endoplasmic reticulum (ER) lumen, where it plays a critical role in maintaining ER homeostasis and promoting cell survival under stress conditions. CDNF is involved in the unfolded protein response (UPR), a cellular stress response related to the ER. It helps manage protein homeostasis by increasing chaperone expression to enhance protein folding, reducing translation to decrease protein load, and promoting the degradation of misfolded proteins (Lindholm2021Cerebral). 

CDNF interacts with ER chaperones such as GRP78 and GRP170, suggesting its involvement in regulating the UPR to promote cell survival. These interactions occur within the ER and are crucial for maintaining ER protein homeostasis (Eesmaa2022CDNF). The protein's structure includes conserved cysteine residues that form disulfide bonds, which are essential for its stability and function (Lindholm2021Cerebral). 

CDNF's role is particularly significant in conditions of ER stress, where it acts as a cofactor to manage stress responses and promote neuronal survival. It does not promote the survival of naïve dopamine neurons but requires stress conditions to exert its anti-apoptotic properties (Eesmaa2022CDNF).

## Clinical Significance
Alterations in the expression or function of the CDNF gene have been implicated in several neurodegenerative diseases, particularly Parkinson's disease (PD). CDNF is known for its neuroprotective effects on dopamine neurons, which are significantly affected in PD. The protein's ability to alleviate endoplasmic reticulum (ER) stress and modulate the unfolded protein response (UPR) is crucial for its protective role. In PD models, CDNF expression reduces markers of nitrosative stress and inflammation, suggesting its potential in reducing neuroinflammation and promoting neuronal survival (Huttunen2019CDNF).

Mutations affecting CDNF's interaction with the UPR regulator GRP78 can impair its neuroprotective activity. Studies have shown that specific mutations in CDNF that disrupt its binding to GRP78 result in a loss of neuroprotective effects, highlighting the importance of this interaction for its function (Graewert2024Structural). Additionally, CDNF's role in modulating UPR pathways, particularly through the IRE1α and PERK pathways, is essential for its anti-apoptotic effects in stressed neurons (Graewert2024Structural).

CDNF's therapeutic potential is being explored, with clinical trials investigating its efficacy in treating PD. Its ability to interact with ER chaperones and modulate stress responses positions CDNF as a promising candidate for neuroprotective therapies (Eesmaa2022CDNF).

## Interactions
CDNF (Cerebral Dopamine Neurotrophic Factor) is known to interact with several proteins involved in the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress pathways. One of the key interactions is with the ER chaperone GRP78, also known as BiP. CDNF binds to the nucleotide-binding domain of GRP78 through its C-terminal domain, which is crucial for its neuroprotective effects. This interaction is essential for CDNF's ability to modulate UPR signaling, particularly through the IRE1α and PERK pathways, and to protect dopamine neurons from stress-induced apoptosis (Graewert2024Structural; Eesmaa2022CDNF).

CDNF also interacts with other ER-localized proteins, including GRP170, suggesting that it may function as a cofactor in the GRP78-GRP170 complex. These interactions have been confirmed using techniques such as affinity purification coupled with mass spectrometry and bimolecular fluorescence complementation assays (Eesmaa2022CDNF).

The interaction between CDNF and GRP78 has been structurally characterized using small-angle X-ray scattering (SAXS) and nuclear magnetic resonance (NMR), which have identified specific residues involved in the binding interface. These studies highlight the importance of disulfide bridges in CDNF for stabilizing its interaction with GRP78 (Graewert2024Structural).


## References


[1. (Huttunen2019CDNF) Henri J. Huttunen and Mart Saarma. Cdnf protein therapy in parkinson’s disease. Cell Transplantation, 28(4):349–366, April 2019. URL: http://dx.doi.org/10.1177/0963689719840290, doi:10.1177/0963689719840290. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/0963689719840290)

[2. (Lindholm2021Cerebral) Päivi Lindholm and Mart Saarma. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Molecular Psychiatry, 27(3):1310–1321, December 2021. URL: http://dx.doi.org/10.1038/s41380-021-01394-6, doi:10.1038/s41380-021-01394-6. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-021-01394-6)

[3. (Parkash2009The) Vimal Parkash, Päivi Lindholm, Johan Peränen, Nisse Kalkkinen, Esko Oksanen, Mart Saarma, Veli-Matti Leppänen, and Adrian Goldman. The structure of the conserved neurotrophic factors manf and cdnf explains why they are bifunctional. Protein Engineering, Design and Selection, 22(4):233–241, January 2009. URL: http://dx.doi.org/10.1093/protein/gzn080, doi:10.1093/protein/gzn080. This article has 100 citations.](https://doi.org/10.1093/protein/gzn080)

[4. (Lindahl2017Unconventional) Maria Lindahl, Mart Saarma, and Päivi Lindholm. Unconventional neurotrophic factors cdnf and manf: structure, physiological functions and therapeutic potential. Neurobiology of Disease, 97:90–102, January 2017. URL: http://dx.doi.org/10.1016/j.nbd.2016.07.009, doi:10.1016/j.nbd.2016.07.009. This article has 137 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.nbd.2016.07.009)

[5. (Stepanova2020Cerebral) P. Stepanova, V. Srinivasan, D. Lindholm, and M. H. Voutilainen. Cerebral dopamine neurotrophic factor (cdnf) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of huntington’s disease. Scientific Reports, November 2020. URL: http://dx.doi.org/10.1038/s41598-020-75439-1, doi:10.1038/s41598-020-75439-1. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-75439-1)

[6. (Tang2017Cerebral) Tingting Tang, Yong Li, Qian Jiao, Xixun Du, and Hong Jiang. Cerebral dopamine neurotrophic factor: a potential therapeutic agent for parkinson’s disease. Neuroscience Bulletin, 33(5):568–575, March 2017. URL: http://dx.doi.org/10.1007/s12264-017-0123-4, doi:10.1007/s12264-017-0123-4. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12264-017-0123-4)

[7. (Graewert2024Structural) Melissa A. Graewert, Maria Volkova, Klara Jonasson, Juha A. E. Määttä, Tobias Gräwert, Samara Mamidi, Natalia Kulesskaya, Johan Evenäs, Richard E. Johnsson, Dmitri Svergun, Arnab Bhattacharjee, and Henri J. Huttunen. Structural basis of cdnf interaction with the upr regulator grp78. Nature Communications, September 2024. URL: http://dx.doi.org/10.1038/s41467-024-52478-0, doi:10.1038/s41467-024-52478-0. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-52478-0)

[8. (Eesmaa2022CDNF) Ave Eesmaa, Li-Ying Yu, Helka Göös, Tatiana Danilova, Kristofer Nõges, Emmi Pakarinen, Markku Varjosalo, Maria Lindahl, Päivi Lindholm, and Mart Saarma. Cdnf interacts with er chaperones and requires upr sensors to promote neuronal survival. International Journal of Molecular Sciences, 23(16):9489, August 2022. URL: http://dx.doi.org/10.3390/ijms23169489, doi:10.3390/ijms23169489. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23169489)